Skip to main content
. 2015 Apr 16;67(2):113–121. doi: 10.3138/ptc.2014-27

Table 3.

Univariate Logistic Regression Model and ORs for the Receipt of PT in LTC across Five Canadian Provinces and One Canadian Territory at Three Durations and Frequencies

Any amount of PT
(n=10,005)
PT ≥45 min on
≥3 d (n=3,277)
PT ≥150 min on
≥5 d (n=349)
Characteristic No. (%) OR (95% CI) No. (%) OR (95% CI) No. (%) OR (95% CI)
Sex
 Female (Ref.) 6,115 (10.7) 1.00 1,303 (4.2) 1.00 114 (0.4 (114) 1.00
 Male 3,890 (12.6) 0.83 (0.80–0.87)* 1,973 (3.5) 0.81 (0.76–0.87)* 190 (0.3) 0.90 (0.72–1.14)
Age group
 <65 y (Ref.) 803 (19.1) 1.00 347 (8.3) 1.00 64 (1.5) 1.00
 65–74 y 943 (13.8) 0.68 (0.61–0.75) 1,709 (3.2) 0.58 (0.50–0.68) 118 (0.2) 0.41 (0.28–0.60)
 75–84 y 2,689 (11.3) 0.54 (0.49–0.59) 879 (3.7) 0.43 (0.37–0.48) 79 (0.3) 0.22 (0.15–0.30)
 ≥85 y 5,570 (10.5) 0.50 (0.46–0.54)* 342 (5.0) 0.37 (0.33–0.42)* 43 (0.6) 0.15 (0.11–0.20)*
Day of stay
 <365 d (Ref.) 847 (13.2) 1.00 208 (3.2) 1.00 17 (0.3) 1.00
 365–730 y 1,604 (13.0) 0.98 (0.90–1.07) 495 (4.0) 1.25 (1.06–1.47) 31 (10.2) 0.95 (0.52–1.71)
 >730 d 7,554 (10.9) 0.81 (0.75–0.87)* 2,574 (3.7) 1.16 (1.00–1.33)† 256 (0.4) 1.40 (0.86–2.29)
Potential for improvement—self rated 1,616 (15.1) 1.46 (1.38–1.55)* 626 (5.8) 1.74 (1.59–1.90)* 87 (0.8) 2.88 (2.24–3.70)*
Potential for improvement—staff rated 1,245 (15.0) 1.43 (1.34–1.53)* 483 (5.8) 1.69 (1.53–1.87)* 62 (0.8) 2.44 (1.84–3.23)*
Clinical status
 No change (stable; Ref.) 6,559 (11.4) 1.00 2,007 (3.5) 1.00 159 (0.3) 1.00
 Deteriorated 2,385 (11.3) 0.99 (0.94–1.04) 713 (3.4) 0.97 (0.89–1.05) 63 (0.3) 1.08 (0.80–1.44)
 Improved 477 (22.3) 2.23 (2.01–2.48)* 237 (11.1) 3.45 (3.00–3.98)* 63 (3.0) 10.96 (8.16–14.72)*
 Experiencing acute episode 767 (13.9) 1.28 (1.18–1.39)* 241 (4.4) 1.12 (1.05–1.37)* 22 (0.4) 1.17 (0.76–1.80)
Conditions
 Multiple sclerosis 319 (20.2) 2.00 (1.76–2.26)* 140 (8.9) 2.57 (2.16–3.07)* 21 (1.3) 4.10 (2.62–6.39)*
 Parkinson's disease 592 (15.4) 1.45 (1.32–1.58)* 183 (4.8) 1.30 (1.12–1.52)* 12 (0.3) 0.89 (0.50–1.58)
 Pneumonia 159 (15.1) 1.40 (1.18–1.66)* 47 (4.5) 1.21 (0.90–1.63) 5 (0.5) 1.39 (0.57–3.36)
 Stroke 2,027 (14.6) 1.42 (1.34–1.49)* 595 (4.3) 1.19 (1.09–1.30)* 38 (0.3) 0.76 (0.54–1.07)
 Any fracture 1,480 (14.4) 1.36 (1.28–1.44)* 525 (5.1) 1.46 (1.33–1.61)* 68 (0.7) 2.18 (1.66–2.86)*
 Hip fracture 1,130 (14.1) 1.31 (1.23–1.40)* 398 (5.0) 1.40 (1.26–1.56)* 48 (0.6) 1.87 (1.38–2.55)*
 Osteoporosis 1,763 (12.0) 1.08 (1.02–1.43)* 583 (4.0) 1.08 (0.99–1.18) 47 (0.3) 0.90 (0.66–1.23)
 Arthritis 3,120 (11.5) 1.02 (0.98–1.07) 1,041 (3.8) 1.04 (0.96–1.12) 91 (0.3) 0.94 (0.74–1.21)
 Huntington's chorea 12 (6.6) 0.55 (0.30–0.98)† 1 (0.6) 0.14 (0.02–1.01)† 1 (0.6) 1.59 (0.22–11.35)
ADL Hierarchy scale score
 0 (no impairment; Ref.) 505 (9.0) 1.00 203 (3.6) 1.00 37 (0.7) 1.00
 1–2 (mild impairment) 171 (9.8) 1.09 (0.99–1.21) 655 (3.7) 1.03 (0.88–1.21) 96 (0.6) 0.83 (0.57–1.21)
 3–4 (moderate impairment) 4,211 (13.2) 1.53 (1.39–1.69) 1,470 (4.6) 0.79 (0.68–0.92) 106 (0.3) 0.30 (0.20–0.45)
 5–6 (severe impairment) 3,572 (10.9) 1.23 (1.11–1.35)* 949 (2.9) 1.28 (1.10–1.49)* 65 (0.2) 0.50 (0.34–0.73)*
CPS score
 0 (no impairment; Ref.) 1,387 (16.7) 1.00 606 (7.3) 1.00 101 (1.2) 1.00
 1–2 (mild impairment) 2,853 (13.0) 0.75 (0.70–0.80) 1,037 (4.7) 0.63 (0.57–0.70) 107 (0.5) 0.40 (0.30–0.52)
 3–4 (moderate impairment) 3,372 (10.5) 0.59 (0.55–0.63) 1,031 (3.2) 0.42 (0.38–0.47) 66 (0.2) 0.17 (0.12–0.23)
 5–6 (severe impairment) 2,393 (9.4) 0.52 (0.48–0.56)* 603 (2.4) 0.31 (0.27–0.35)* 30 (0.1) 0.10 (0.06–0.14)*
Pain score
 0 (no pain; Ref.) 4,227 (10.5) 1.00 1,291 (3.2) 1.00 115 (0.3) 1.00
 1–2 (daily mild to moderate pain) 5,285 (12.2) 1.18 (1.13–1.24) 1,824 (4.2) 1.33 (1.23–1.43) 175 (0.4) 1.42 (1.12–1.79)
 3 (daily excruciating pain) 493 (12.3) 1.20 (1.08–1.33)* 162 (4.1) 1.28 (1.08–1.51)* 14 (0.4) 1.23 (0.71–2.15)†
DRS score
 0 (no depression; Ref.) 5,016 (12.4) 1.00 1,703 (4.2) 1.00 191 (0.5) 1.00
 1–2 (mild depression) 2,784 (10.4) 0.82 (0.78–0.87) 909 (3.4) 0.80 (0.74–0.87) 70 (0.3) 0.55 (0.42–0.73)
 3+ (evidence of depression) 2,186 (10.7) 0.85 (0.81–0.90)* 656 (3.2) 0.76 (0.69–0.83)* 42 (0.2) 0.44 (0.31–0.61)*
Falls CAP
 Not triggered (Ref.) 8,352 (11.3) 1.00 2,776 (3.7) 1.00 250 (0.3) 1.00
 Medium risk 1,043 (12.0) 1.07 (1.00–1.15) 318 (3.6) 0.97 (0.87–1.10) 47 (0.5) 1.60 (1.17–2.19)
 High risk 603 (12.4) 1.11 (1.02–1.21)* 182 (3.7) 1.00 (0.86–1.16) 7 (0.1) 0.43 (0.20–0.90)*
Urinary incontinence CAP
 Not triggered (Ref.) 4,242 (10.6) 1.00 1,307 (3.3) 1.00 153 (0.4) 1.00
 Facilitate improvement 509 (11.4) 1.08 (0.98–1.19) 166 (3.7) 1.14 (0.97–1.35) 106 (0.3) 1.46 (0.96–2.24)
 Prevent decline 4,660 (12.9) 1.25 (1.19–1.30)* 1,478 (4.1) 1.26 (1.17–1.36)* 25 (0.6) 0.77 (0.60–0.98)
Province
 British Columbia (Ref.) 5,913 (12.3) 1.00 1,545 (3.2) 1.00 116 (0.2) 1.00
 Manitoba 725 (5.8) 0.43 (0.40–0.47) 233 (1.9) 0.57 (0.49–0.65) 5 (0.04) 0.16 (0.07–0.40)
 Newfoundland & Labrador 438 (27.0) 2.63 (2.35–2.94) 49 (3.0) 0.94 (0.70–1.25) 2 (0.1) 0.51 (0.13–2.06)
 Nova Scotia 620 (29.5) 2.98 (2.71–3.29) 148 (7.1) 2.28 (1.92–2.72) 10 (0.5) 1.98 (1.03–3.77)
 Saskatchewan 2,226 (9.6) 0.76 (0.72–0.80) 1,283 (5.5) 1.76 (1.63–1.90) 170 (0.7) 3.05 (2.41–3.86)
 Yukon 83 (24.0) 2.25 (1.75–2.88)* 19 (5.5) 1.75 (1.10–2.78)* 1 (0.7) 1.20 (0.17–8.59)*

*p<0.01. †p<0.05.

PT=physical therapy; OR=unadjusted odds ratio; ADL=activities of daily living; CPS=Cognitive Performance Scale; DRS=Depression Rating Scale, CAP=Clinical Assessment Protocol.